Package 21922-020-12

Brand: tavaborole

Generic: tavaborole topical solution, 5%
NDC Package

Package Facts

Identity

Package NDC 21922-020-12
Digits Only 2192202012
Product NDC 21922-020
Product ID 21922-020_10a126f9-ec1b-44d2-8611-3d6660a53ae8
Description

1 BOTTLE, WITH APPLICATOR in 1 CARTON (21922-020-12) / 10 mL in 1 BOTTLE, WITH APPLICATOR

Marketing

Marketing Status
Marketed Since 2020-10-19
Brand tavaborole
Generic tavaborole topical solution, 5%
Sample Package No

Linked Drug Pages (1)

Tavaborole ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "10a126f9-ec1b-44d2-8611-3d6660a53ae8", "openfda": {"nui": ["N0000191279", "N0000000150", "M0002832"], "unii": ["K124A4EUQ3"], "rxcui": ["1543177"], "spl_set_id": ["050f5d10-5591-426e-9020-6516b3363304"], "pharm_class_cs": ["Boron Compounds [CS]"], "pharm_class_epc": ["Oxaborole Antifungal [EPC]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Encube Ethicals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, WITH APPLICATOR in 1 CARTON (21922-020-12)  / 10 mL in 1 BOTTLE, WITH APPLICATOR", "package_ndc": "21922-020-12", "marketing_start_date": "20201019"}], "brand_name": "Tavaborole", "product_id": "21922-020_10a126f9-ec1b-44d2-8611-3d6660a53ae8", "dosage_form": "SOLUTION", "pharm_class": ["Boron Compounds [CS]", "Oxaborole Antifungal [EPC]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "21922-020", "generic_name": "TAVABOROLE topical solution, 5%", "labeler_name": "Encube Ethicals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tavaborole", "active_ingredients": [{"name": "TAVABOROLE", "strength": "43.5 mg/mL"}], "application_number": "ANDA211297", "marketing_category": "ANDA", "marketing_start_date": "20201019", "listing_expiration_date": "20261231"}